Ming‐Lung Yu

23.1k citations
495 papers · 11.1k · 1 hit paper · h-index 54

Impact in

  • Hepatology top 0.05%
    • Hepatitis C virus research
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Hepatitis Viruses Studies and Epidemiology
  • Epidemiology top 0.1%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 240
    • Hepatocellular Carcinoma Treatment and Prognosis 21
    • Liver Disease and Transplantation 15
    • Liver Disease Diagnosis and Treatment 171
    • Hepatitis B Virus Studies 135

Ming‐Lung Yu

474 papers receiving 10.9k citations

Ming‐Lung Yu's Hit Papers

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region 2023 · 93 citations
930+1+2Years since publication255075

Peers

Ming‐Lung Yu
Comparison fields: 5 of 146
  • Hepatology 6.2k
  • Epidemiology 5.3k
  • Endocrinology, Diabetes and Metabolism 543
  • Infectious Diseases 476
  • Rheumatology 375
Replace Chia‐Yen Dai with:
Chia‐Yen Dai Taiwan
Wan‐Long Chuang Taiwan
Frederik Nevens Belgium
San‐Lin You Taiwan
Robert G. Gish United States
Angelo Andriulli Italy
Ramsey Cheung United States
Robert J. de Knegt Netherlands
Graeme Alexander United Kingdom
Pietro Invernizzi Italy
Ming‐Lung Yu relative to Chia‐Yen Dai Taiwan Chia‐Yen Dai's profile →
Citations per field
00.5×1.5×2.2×
Chia‐Yen Dai · 1×
Citations per year

Countries citing papers authored by Ming‐Lung Yu

Since Specialization
Citations

This map shows the geographic impact of Ming‐Lung Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Lung Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Lung Yu more than expected).

Fields of papers citing papers by Ming‐Lung Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Lung Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Lung Yu. The network helps show where Ming‐Lung Yu may publish in the future.

Co-authors

The 25 scholars most cited alongside Ming‐Lung Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming‐Lung Yu Line = papers co-authored together Ming‐Lung Yu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 495 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006246
2 2006215
3 2008207
4 2009205
5 2010154
6 2006146
7 2008145
8 2012132
9 2012127
10 2009122
11 2019122
12 2018120
13 2008118
14 2006116
15 2007100
16 201495
17
Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region
Hit paper breakdown →
202393
18 201092
19 200691
20 202091

About Ming‐Lung Yu

Ming‐Lung Yu is a scholar working on Hepatology, Epidemiology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 495 papers that have together received 11.1k indexed citations. Recurring topics across this work include Hepatitis C virus research (240 papers), Liver Disease Diagnosis and Treatment (171 papers), Hepatitis B Virus Studies (135 papers), Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Liver Disease and Transplantation (15 papers), Systemic Lupus Erythematosus Research (11 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Animal Virus Infections Studies (9 papers). The work is most often cited by research in Hepatology (6.2k citations), Epidemiology (5.3k citations), Endocrinology, Diabetes and Metabolism (543 citations), Infectious Diseases (476 citations) and Rheumatology (375 citations). Ming‐Lung Yu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Wan‐Long Chuang, Chia‐Yen Dai, Jee‐Fu Huang, Zu‐Yau Lin, Chung‐Feng Huang, Liang‐Yen Wang, Shinn‐Cherng Chen, Ming‐Lun Yeh, Ming‐Yuh Hsieh and Ming‐Yen Hsieh. Their work appears in journals such as Journal of Gastroenterology and Hepatology, PLoS ONE, Hepatology International, Journal of Hepatology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact